What is CytomX Therapeutics, Inc.'s Market Cap?

CytomX Therapeutics, Inc.'s Market Cap is $795.3M, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s Enterprise Value?

CytomX Therapeutics, Inc.'s Enterprise Value is $778.1M, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s Price / Sales?

CytomX Therapeutics, Inc.'s Price / Sales is 43.5×, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s EV / Revenue?

CytomX Therapeutics, Inc.'s EV / Revenue is 42.5×, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s EV / EBITDA?

CytomX Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s Revenue (TTM)?

CytomX Therapeutics, Inc.'s Revenue (TTM) is $18.3M, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s Net Income (TTM)?

CytomX Therapeutics, Inc.'s Net Income (TTM) is -$79.7M, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s EBITDA?

CytomX Therapeutics, Inc.'s EBITDA is -$85.8M, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s Diluted EPS (TTM)?

CytomX Therapeutics, Inc.'s Diluted EPS (TTM) is -0.37, based on as-reported figures from SEC (XBRL) filings.

What is CytomX Therapeutics, Inc.'s EBITDA Margin?

CytomX Therapeutics, Inc.'s EBITDA Margin is -468.8%, based on as-reported figures from SEC (XBRL) filings.

CytomX Therapeutics, Inc. (CTMX) Financial Statements

CytomX Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0GS49

XNAS · usd

3.65▼ 0.06 (-1.62%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close3.71

Day's Range3.58 – 3.66

52-Week Range1.90 – 8.21

Volume2.0M

Avg Volume2.8M

Share Statistics

Shares Outstanding

Employees69

ExchangeXNAS

Listed2015-10-08

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about CytomX Therapeutics, Inc. (CTMX)

What is CytomX Therapeutics, Inc.'s Market Cap?: CytomX Therapeutics, Inc.'s Market Cap is $795.3M, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s Enterprise Value?: CytomX Therapeutics, Inc.'s Enterprise Value is $778.1M, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s Price / Sales?: CytomX Therapeutics, Inc.'s Price / Sales is 43.5×, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s EV / Revenue?: CytomX Therapeutics, Inc.'s EV / Revenue is 42.5×, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s EV / EBITDA?: CytomX Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s Revenue (TTM)?: CytomX Therapeutics, Inc.'s Revenue (TTM) is $18.3M, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s Net Income (TTM)?: CytomX Therapeutics, Inc.'s Net Income (TTM) is -$79.7M, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s EBITDA?: CytomX Therapeutics, Inc.'s EBITDA is -$85.8M, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s Diluted EPS (TTM)?: CytomX Therapeutics, Inc.'s Diluted EPS (TTM) is -0.37, based on as-reported figures from SEC (XBRL) filings.
What is CytomX Therapeutics, Inc.'s EBITDA Margin?: CytomX Therapeutics, Inc.'s EBITDA Margin is -468.8%, based on as-reported figures from SEC (XBRL) filings.